Anti-LRCH1 monoclonal antibody

Pre-made anti-LRCH1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LRCH1/LRCH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1106-Ab-1/ GM-Tg-hg-IP1106-Ab-2Anti-Human LRCH1 monoclonal antibodyHuman
GM-Tg-rg-IP1106-Ab-1/ GM-Tg-rg-IP1106-Ab-2Anti-Rat LRCH1 monoclonal antibodyRat
GM-Tg-mg-IP1106-Ab-1/ GM-Tg-mg-IP1106-Ab-2Anti-Mouse LRCH1 monoclonal antibodyMouse
GM-Tg-cynog-IP1106-Ab-1/ GM-Tg-cynog-IP1106-Ab-2Anti-Cynomolgus/ Rhesus macaque LRCH1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1106-Ab-1/ GM-Tg-felg-IP1106-Ab-2Anti-Feline LRCH1 monoclonal antibodyFeline
GM-Tg-cang-IP1106-Ab-1/ GM-Tg-cang-IP1106-Ab-2Anti-Canine LRCH1 monoclonal antibodyCanine
GM-Tg-bovg-IP1106-Ab-1/ GM-Tg-bovg-IP1106-Ab-2Anti-Bovine LRCH1 monoclonal antibodyBovine
GM-Tg-equg-IP1106-Ab-1/ GM-Tg-equg-IP1106-Ab-2Anti-Equine LRCH1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1106-Ab-1/ GM-Tg-hg-IP1106-Ab-2; GM-Tg-rg-IP1106-Ab-1/ GM-Tg-rg-IP1106-Ab-2;
GM-Tg-mg-IP1106-Ab-1/ GM-Tg-mg-IP1106-Ab-2; GM-Tg-cynog-IP1106-Ab-1/ GM-Tg-cynog-IP1106-Ab-2;
GM-Tg-felg-IP1106-Ab-1/ GM-Tg-felg-IP1106-Ab-2; GM-Tg-cang-IP1106-Ab-1/ GM-Tg-cang-IP1106-Ab-2;
GM-Tg-bovg-IP1106-Ab-1/ GM-Tg-bovg-IP1106-Ab-2; GM-Tg-equg-IP1106-Ab-1/ GM-Tg-equg-IP1106-Ab-2
Products NameAnti-LRCH1 monoclonal antibody
Formatmab
Target NameLRCH1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LRCH1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1106-Ag-1Recombinant multi-species LRCH1/ CHDC1/ NP81 protein
    ORF Viral VectorpGMLPm003876mouse Lrch1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003876mouse Lrch1 Lentivirus particle


    Target information

    Target IDGM-IP1106
    Target NameLRCH1
    Gene ID23143,380916,502020,708778,476919,727691,505325,100058140
    Gene Symbol and Synonyms4832412D13Rik,CHDC1,LRCH1,mKIAA1016,NP81
    Uniprot AccessionQ9Y2L9,P41737
    Uniprot Entry NameLRCH1_HUMAN,LRCH1_FELCA
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136141
    Target ClassificationN/A

    The target: LRCH1, gene name: LRCH1, also named as CHDC1, NP81. This gene encodes a protein with a leucine-rich repeat and a calponin homology domain. Polymorphism in this gene may be associated with susceptibililty to knee osteoarthritis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.